The double-edged sword of neutrophilic inflammation in bronchiectasis
- PMID: 26424521
- DOI: 10.1183/13993003.00961-2015
The double-edged sword of neutrophilic inflammation in bronchiectasis
Comment on
-
A randomised, placebo-controlled study of the CXCR2 antagonist AZD5069 in bronchiectasis.Eur Respir J. 2015 Oct;46(4):1021-32. doi: 10.1183/13993003.00148-2015. Epub 2015 Sep 4. Eur Respir J. 2015. PMID: 26341987 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources